Last 12 months
Inside the activity.
0 purchase rows · 64 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 24 |
| Dec 2025 | 0 | 6 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 12 |
| Mar 2026 | 0 | 13 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 2 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 4 |
| Sep 2026 | 0 | 3 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 09, 2018 Filed May 11, 2018 21:20 UTC |
Horton AmyVP, Chief Accounting Officer
|
SaleCommon Stock | 4,000 | $25.94 | $103,763.60 |
DisclosureSEC source: 0000784199-18-000093 · certent-form4.xml · nonDerivative · entry 1 Horton Amy · CIK 0001371523 · VP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,959 F1 · price: Reflects weighted average price. Range was between $25.93 - $25.95. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. Read SEC document |
| May 08, 2018 Filed May 10, 2018 20:43 UTC |
Davis John ESenior VP, Global Sales
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 4,373 | $10.24 Strike: $10.24 | $44,779.52 |
DisclosureSEC source: 0000784199-18-000091 · certent-form4.xml · derivative · entry 3 Davis John E · CIK 0001653206 · Senior VP, Global Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,491 Underlying: Common Stock · 4,373 shares Expires 2023-02-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date. The first exercisable date was 2/19/2017 Read SEC document |
| May 08, 2018 Filed May 10, 2018 20:43 UTC |
Davis John ESenior VP, Global Sales
|
SaleCommon Stock | 4,373 | $26.00 | $113,698.00 |
DisclosureSEC source: 0000784199-18-000091 · certent-form4.xml · nonDerivative · entry 2 Davis John E · CIK 0001653206 · Senior VP, Global Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,438 F2 · price: Reflects the price of $26 the shares were sold. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at this price Read SEC document |
| May 08, 2018 Filed May 10, 2018 20:43 UTC |
Davis John ESenior VP, Global Sales
|
Exercise / conversionCommon Stock | 4,373 | $10.24 | $44,779.52 |
DisclosureSEC source: 0000784199-18-000091 · certent-form4.xml · nonDerivative · entry 1 Davis John E · CIK 0001653206 · Senior VP, Global Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,811 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sale reported on this form was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on December 8, 2017. Read SEC document |
| May 08, 2018 Filed May 10, 2018 20:41 UTC |
RONALD C ELKINSDirector
|
SaleCommon Stock | 1,852 | $25.58 | $47,378.60 |
DisclosureSEC source: 0000784199-18-000089 · certent-form4.xml · nonDerivative · entry 1 RONALD C ELKINS · CIK 0001016744 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,997 F1 · price: Reflects the weighted avg price of $25.5824 the shares were sold. The range was from $25.65 to $25.55. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at this price. Read SEC document |
| May 08, 2018 Filed May 15, 2018 21:30 UTC |
McCall Ronald DDirector
|
SaleCommon Stock | 260 | $25.95 | $6,747.00 |
DisclosureSEC source: 0000784199-18-000099 · certent-form4.xml · nonDerivative · entry 1 McCall Ronald D · CIK 0001016766 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 142,011 F1 · price: Reflects the price of $25.95 the shares were sold. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at this price. Read SEC document |
| May 03, 2018 Filed May 8, 2018 20:26 UTC |
RONALD C ELKINSDirector
|
SaleCommon Stock | 2,000 | $24.00 | $48,000.00 |
DisclosureSEC source: 0000784199-18-000087 · certent-form4.xml · nonDerivative · entry 1 RONALD C ELKINS · CIK 0001016744 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,849 F1 · shares: The sale reported on this form was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on September 16, 2016. F2 · price: Reflects the price of $24 the shares were sold. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at this price. Read SEC document |
| May 03, 2018 Filed May 8, 2018 20:24 UTC |
Davis John ESenior VP, Global Sales
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 3,334 | $9.64 Strike: $9.64 | $32,139.76 |
DisclosureSEC source: 0000784199-18-000085 · certent-form4.xml · derivative · entry 3 Davis John E · CIK 0001653206 · Senior VP, Global Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,333 Underlying: Common Stock · 3,334 shares Expires 2022-09-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date. The first exercisable date was 9/10/2016. Read SEC document |
| May 03, 2018 Filed May 8, 2018 20:24 UTC |
Davis John ESenior VP, Global Sales
|
SaleCommon Stock | 3,334 | $24.00 | $80,016.00 |
DisclosureSEC source: 0000784199-18-000085 · certent-form4.xml · nonDerivative · entry 2 Davis John E · CIK 0001653206 · Senior VP, Global Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,438 F1 · shares: The sale reported on this form was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on December 8, 2017. F2 · price: Reflects the price of $24 the shares were sold. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at this price Read SEC document |
| May 03, 2018 Filed May 8, 2018 20:24 UTC |
Davis John ESenior VP, Global Sales
|
Exercise / conversionCommon Stock | 3,334 | $9.64 | $32,139.76 |
DisclosureSEC source: 0000784199-18-000085 · certent-form4.xml · nonDerivative · entry 1 Davis John E · CIK 0001653206 · Senior VP, Global Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,772 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sale reported on this form was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on December 8, 2017. Read SEC document |
| April 17, 2018 Filed Apr 18, 2018 20:42 UTC |
Davis John ESenior VP, Global Sales
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 3,333 | $9.64 Strike: $9.64 | $32,130.12 |
DisclosureSEC source: 0000784199-18-000081 · certent-form4.xml · derivative · entry 3 Davis John E · CIK 0001653206 · Senior VP, Global Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,667 Underlying: Common Stock · 3,333 shares Expires 2022-09-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date. The first exercisable date was 9/10/2016. Read SEC document |
| April 17, 2018 Filed Apr 18, 2018 20:42 UTC |
Davis John ESenior VP, Global Sales
|
SaleCommon Stock | 3,333 | $23.00 | $76,659.00 |
DisclosureSEC source: 0000784199-18-000081 · certent-form4.xml · nonDerivative · entry 2 Davis John E · CIK 0001653206 · Senior VP, Global Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,438 F1 · kind: The sale reported on this form was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on December 8, 2017. Read SEC document |
| April 17, 2018 Filed Apr 18, 2018 20:42 UTC |
Davis John ESenior VP, Global Sales
|
Exercise / conversionCommon Stock | 3,333 | $9.64 | $32,130.12 |
DisclosureSEC source: 0000784199-18-000081 · certent-form4.xml · nonDerivative · entry 1 Davis John E · CIK 0001653206 · Senior VP, Global Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,771 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 01, 2018 Filed Apr 3, 2018 12:58 UTC |
Holloway Jean FVP, General Counsel
|
Tax withholdingCommon Stock | 2,125 | $20.05 | $42,606.25 |
DisclosureSEC source: 0000784199-18-000079 · certent-form4.xml · nonDerivative · entry 1 Holloway Jean F · CIK 0001540065 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,877 F1 · shares: Represent shares of restricted stock that were withheld for taxes on the grant vest date. Read SEC document |
| March 12, 2018 Filed Mar 14, 2018 23:52 UTC |
McDermid James MSVP, CHRO
|
GrantStock Option (Right to Buy) · Derivative | 15,910 | $0.00 Strike: $21.55 | $0.00 |
DisclosureSEC source: 0000784199-18-000075 · certent-form4.xml · derivative · entry 2 McDermid James M · CIK 0001681601 · SVP, CHRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,910 Underlying: Common Stock · 15,910 shares Expires 2025-03-12 Read SEC document |
| March 12, 2018 Filed Mar 14, 2018 23:52 UTC |
McDermid James MSVP, CHRO
|
GrantCommon Stock | 6,187 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-18-000075 · certent-form4.xml · nonDerivative · entry 1 McDermid James M · CIK 0001681601 · SVP, CHRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,339 F1 · shares: Represents share of restricted stock that vest on the third anniversary of the grant date if the reporting person remains in the continuous employ of the Company. Read SEC document |
| March 12, 2018 Filed Mar 14, 2018 23:51 UTC |
Mackin James PPresident & CEO
|
GrantStock Option (Right to Buy) · Derivative | 77,562 | $0.00 Strike: $21.55 | $0.00 |
DisclosureSEC source: 0000784199-18-000073 · certent-form4.xml · derivative · entry 2 Mackin James P · CIK 0001408470 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,562 Underlying: Common Stock · 77,562 shares Expires 2025-03-12 Read SEC document |
| March 12, 2018 Filed Mar 14, 2018 23:51 UTC |
Mackin James PPresident & CEO
|
GrantCommon Stock | 30,162 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-18-000073 · certent-form4.xml · nonDerivative · entry 1 Mackin James P · CIK 0001408470 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 351,095 F1 · shares: Represents share of restricted stock that vest on the third anniversary of the grant date if the reporting person remains in the continuous employ of the Company. Read SEC document |
| March 12, 2018 Filed Mar 14, 2018 23:50 UTC |
LEE DAVID ASHLEYExecutive VP, COO & CFO
|
GrantStock Option (Right to Buy) · Derivative | 21,877 | $0.00 Strike: $21.55 | $0.00 |
DisclosureSEC source: 0000784199-18-000071 · certent-form4.xml · derivative · entry 2 LEE DAVID ASHLEY · CIK 0001112830 · Executive VP, COO & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,877 Underlying: Common Stock · 21,877 shares Expires 2025-03-12 Read SEC document |
| March 12, 2018 Filed Mar 14, 2018 23:50 UTC |
LEE DAVID ASHLEYExecutive VP, COO & CFO
|
GrantCommon Stock | 8,507 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-18-000071 · certent-form4.xml · nonDerivative · entry 1 LEE DAVID ASHLEY · CIK 0001112830 · Executive VP, COO & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 300,079 F1 · shares: Represents share of restricted stock that vest on the third anniversary of the grant date if the reporting person remains in the continuous employ of the Company. Read SEC document |
| March 12, 2018 Filed Mar 14, 2018 23:50 UTC |
Horton AmyVP, Chief Accounting Officer
|
GrantStock Option (Right to Buy) · Derivative | 12,430 | $0.00 Strike: $21.55 | $0.00 |
DisclosureSEC source: 0000784199-18-000069 · certent-form4.xml · derivative · entry 2 Horton Amy · CIK 0001371523 · VP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,430 Underlying: Common Stock · 12,430 shares Expires 2025-03-12 Read SEC document |
| March 12, 2018 Filed Mar 14, 2018 23:50 UTC |
Horton AmyVP, Chief Accounting Officer
|
GrantCommon Stock | 4,834 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-18-000069 · certent-form4.xml · nonDerivative · entry 1 Horton Amy · CIK 0001371523 · VP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,959 F1 · shares: Represents share of restricted stock that vest on the third anniversary of the grant date if the reporting person remains in the continuous employ of the Company. Read SEC document |
| March 12, 2018 Filed Mar 14, 2018 23:49 UTC |
Holloway Jean FVP, General Counsel
|
GrantStock Option (Right to Buy) · Derivative | 19,092 | $0.00 Strike: $21.55 | $0.00 |
DisclosureSEC source: 0000784199-18-000067 · certent-form4.xml · derivative · entry 2 Holloway Jean F · CIK 0001540065 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,092 Underlying: Common Stock · 19,092 shares Expires 2025-03-12 Read SEC document |
| March 12, 2018 Filed Mar 14, 2018 23:49 UTC |
Holloway Jean FVP, General Counsel
|
GrantCommon Stock | 7,425 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-18-000067 · certent-form4.xml · nonDerivative · entry 1 Holloway Jean F · CIK 0001540065 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,002 F1 · shares: Represents share of restricted stock that vest on the third anniversary of the grant date if the reporting person remains in the continuous employ of the Company. Read SEC document |
| March 12, 2018 Filed Mar 14, 2018 23:48 UTC |
Davis John ESenior VP, Global Sales
|
GrantStock Option (Right to Buy) · Derivative | 15,910 | $0.00 Strike: $21.55 | $0.00 |
DisclosureSEC source: 0000784199-18-000065 · certent-form4.xml · derivative · entry 2 Davis John E · CIK 0001653206 · Senior VP, Global Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,910 Underlying: Common Stock · 15,910 shares Expires 2025-03-12 Read SEC document |
| March 12, 2018 Filed Mar 14, 2018 23:48 UTC |
Davis John ESenior VP, Global Sales
|
GrantCommon Stock | 6,187 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-18-000065 · certent-form4.xml · nonDerivative · entry 1 Davis John E · CIK 0001653206 · Senior VP, Global Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,438 F1 · shares: Represents share of restricted stock that vest on the third anniversary of the grant date if the reporting person remains in the continuous employ of the Company. Read SEC document |
| March 12, 2018 Filed Mar 14, 2018 23:47 UTC |
Capps Scott BVP, Clinical Research
|
GrantStock Option (Right to Buy) · Derivative | 9,944 | $0.00 Strike: $21.55 | $0.00 |
DisclosureSEC source: 0000784199-18-000063 · certent-form4.xml · derivative · entry 2 Capps Scott B · CIK 0001409753 · VP, Clinical Research 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,944 Underlying: Common Stock · 9,944 shares Expires 2025-03-12 Read SEC document |
| March 12, 2018 Filed Mar 14, 2018 23:47 UTC |
Capps Scott BVP, Clinical Research
|
GrantCommon Stock | 3,867 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-18-000063 · certent-form4.xml · nonDerivative · entry 1 Capps Scott B · CIK 0001409753 · VP, Clinical Research 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 139,087 F1 · shares: Represents share of restricted stock that vest on the third anniversary of the grant date if the reporting person remains in the continuous employ of the Company. Read SEC document |
| March 08, 2018 Filed Mar 9, 2018 21:51 UTC |
McCall Ronald DDirector
|
SaleCommon Stock | 5,000 | $21.09 | $105,447.50 |
DisclosureSEC source: 0000784199-18-000059 · certent-form4.xml · nonDerivative · entry 1 McCall Ronald D · CIK 0001016766 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 146,511 F1 · shares: The sale reported on this form was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on November 14, 2017 F2 · price: Reflects weighted average price. Range of prices were between $21 to $21.25. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| March 08, 2018 Filed Mar 9, 2018 21:51 UTC |
RONALD C ELKINSDirector
|
SaleCommon Stock | 2,000 | $22.00 | $44,000.00 |
DisclosureSEC source: 0000784199-18-000056 · certent-form4.xml · nonDerivative · entry 1 RONALD C ELKINS · CIK 0001016744 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,849 F1 · shares: The sale reported on this form was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on September 16, 2016. F2 · price: Reflects the price of $22 the shares were sold. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at this price. Read SEC document |
| March 05, 2018 Filed Mar 7, 2018 22:26 UTC |
Mackin James PPresident & CEO
|
Tax withholdingCommon Stock | 6,349 | $19.15 | $121,583.35 |
DisclosureSEC source: 0000784199-18-000050 · certent-form4.xml · nonDerivative · entry 2 Mackin James P · CIK 0001408470 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 320,933 F2 · shares: These shares were withheld upon the vesting of performance stock units to pay tax withholding obligations. Read SEC document |
| March 05, 2018 Filed Mar 7, 2018 22:26 UTC |
Mackin James PPresident & CEO
|
GrantCommon Stock | 28,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-18-000050 · certent-form4.xml · nonDerivative · entry 1 Mackin James P · CIK 0001408470 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 327,282 F1 · shares: Represents performance stock units granted on February 21, 2017 and earned at approximately 90% of target based on 2017 adjusted EBITDA. Fifty percent (50%) were issued on March 5, 2018. The remaining shares earned in connection with the February 2017 grant will vest and be issued as follows: 50% on 02/21/2019, and 50% on 02/21/2020, assuming continued employment on the relevant vesting date. Read SEC document |
| March 05, 2018 Filed Mar 7, 2018 22:26 UTC |
McDermid James MSVP, CHRO
|
Tax withholdingCommon Stock | 997 | $19.15 | $19,092.55 |
DisclosureSEC source: 0000784199-18-000052 · certent-form4.xml · nonDerivative · entry 2 McDermid James M · CIK 0001681601 · SVP, CHRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,152 F2 · shares: These shares were withheld upon the vesting of performance stock units to pay tax withholding obligations. Read SEC document |
| March 05, 2018 Filed Mar 7, 2018 22:26 UTC |
McDermid James MSVP, CHRO
|
GrantCommon Stock | 5,652 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-18-000052 · certent-form4.xml · nonDerivative · entry 1 McDermid James M · CIK 0001681601 · SVP, CHRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,149 F1 · shares: Represents performance stock units granted on February 21, 2017 and earned at approximately 90% of target based on 2017 adjusted EBITDA. Fifty percent (50%) were issued on March 5, 2018. The remaining shares earned in connection with the February 2017 grant will vest and be issued as follows: 50% on 02/21/2019, and 50% on 02/21/2020, assuming continued employment on the relevant vesting date. Read SEC document |
| March 05, 2018 Filed Mar 7, 2018 22:26 UTC |
LEE DAVID ASHLEYExecutive VP, COO & CFO
|
Tax withholdingCommon Stock | 1,245 | $19.15 | $23,841.75 |
DisclosureSEC source: 0000784199-18-000048 · certent-form4.xml · nonDerivative · entry 2 LEE DAVID ASHLEY · CIK 0001112830 · Executive VP, COO & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 291,572 F2 · shares: These shares were withheld upon the vesting of performance stock units to pay tax withholding obligations. Read SEC document |
| March 05, 2018 Filed Mar 7, 2018 22:26 UTC |
LEE DAVID ASHLEYExecutive VP, COO & CFO
|
GrantCommon Stock | 8,200 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-18-000048 · certent-form4.xml · nonDerivative · entry 1 LEE DAVID ASHLEY · CIK 0001112830 · Executive VP, COO & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 292,817 F1 · shares: Represents performance stock units granted on February 21, 2017 and earned at approximately 90% of target based on 2017 adjusted EBITDA. Fifty percent (50%) were issued on March 5, 2018. The remaining shares earned in connection with the February 2017 grant will vest and be issued as follows: 50% on 02/21/2019, and 50% on 02/21/2020, assuming continued employment on the relevant vesting date. Read SEC document |
| March 05, 2018 Filed Mar 7, 2018 22:26 UTC |
Horton AmyVP, Chief Accounting Officer
|
Tax withholdingCommon Stock | 698 | $19.15 | $13,366.70 |
DisclosureSEC source: 0000784199-18-000045 · certent-form4.xml · nonDerivative · entry 2 Horton Amy · CIK 0001371523 · VP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,125 F2 · shares: These shares were withheld upon the vesting of performance stock units to pay tax withholding obligations. Read SEC document |
| March 05, 2018 Filed Mar 7, 2018 22:26 UTC |
Horton AmyVP, Chief Accounting Officer
|
GrantCommon Stock | 4,600 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-18-000045 · certent-form4.xml · nonDerivative · entry 1 Horton Amy · CIK 0001371523 · VP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,823 F1 · shares: Represents performance stock units granted on February 21, 2017 and earned at approximately 90% of target based on 2017 adjusted EBITDA. Fifty percent (50%) were issued on March 5, 2018. The remaining shares earned in connection with the February 2017 grant will vest and be issued as follows: 50% on 02/21/2019, and 50% on 02/21/2020, assuming continued employment on the relevant vesting date. Read SEC document |
| March 05, 2018 Filed Mar 7, 2018 22:19 UTC |
Holloway Jean FVP, General Counsel
|
Tax withholdingCommon Stock | 1,022 | $19.15 | $19,571.30 |
DisclosureSEC source: 0000784199-18-000043 · certent-form4.xml · nonDerivative · entry 2 Holloway Jean F · CIK 0001540065 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,577 F2 · shares: These shares were withheld upon the vesting of performance stock units to pay tax withholding obligations. Read SEC document |
| March 05, 2018 Filed Mar 7, 2018 22:19 UTC |
Holloway Jean FVP, General Counsel
|
GrantCommon Stock | 6,782 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-18-000043 · certent-form4.xml · nonDerivative · entry 1 Holloway Jean F · CIK 0001540065 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,599 F1 · shares: Represents performance stock units granted on February 21, 2017 and earned at approximately 90% of target based on 2017 adjusted EBITDA. Fifty percent (50%) were issued on March 5, 2018. The remaining shares earned in connection with the February 2017 grant will vest and be issued as follows: 50% on 02/21/2019, and 50% on 02/21/2020, assuming continued employment on the relevant vesting date. Read SEC document |
| March 05, 2018 Filed Mar 7, 2018 22:19 UTC |
Davis John ESenior VP, Global Sales
|
Tax withholdingCommon Stock | 957 | $19.15 | $18,326.55 |
DisclosureSEC source: 0000784199-18-000041 · certent-form4.xml · nonDerivative · entry 2 Davis John E · CIK 0001653206 · Senior VP, Global Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,251 F2 · shares: These shares were withheld upon the vesting of performance stock units to pay tax withholding obligations. Read SEC document |
| March 05, 2018 Filed Mar 7, 2018 22:19 UTC |
Davis John ESenior VP, Global Sales
|
GrantCommon Stock | 6,500 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-18-000041 · certent-form4.xml · nonDerivative · entry 1 Davis John E · CIK 0001653206 · Senior VP, Global Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,208 F1 · shares: Represents performance stock units granted on February 21, 2017 and earned at approximately 90% of target based on 2017 adjusted EBITDA. Fifty percent (50%) were issued on March 5, 2018. The remaining shares earned in connection with the February 2017 grant will vest and be issued as follows: 50% on 02/21/2019, and 50% on 02/21/2020, assuming continued employment on the relevant vesting date. Read SEC document |
| March 05, 2018 Filed Mar 7, 2018 22:19 UTC |
Capps Scott BVP, Clinical Research
|
Tax withholdingCommon Stock | 607 | $19.15 | $11,624.05 |
DisclosureSEC source: 0000784199-18-000038 · certent-form4.xml · nonDerivative · entry 2 Capps Scott B · CIK 0001409753 · VP, Clinical Research 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 135,220 F2 · shares: These shares were withheld upon the vesting of performance stock units to pay tax withholding obligations. Read SEC document |
| March 05, 2018 Filed Mar 7, 2018 22:19 UTC |
Capps Scott BVP, Clinical Research
|
GrantCommon Stock | 4,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-18-000038 · certent-form4.xml · nonDerivative · entry 1 Capps Scott B · CIK 0001409753 · VP, Clinical Research 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 135,827 F1 · shares: Represents performance stock units granted on February 21, 2017 and earned at approximately 90% of target based on 2017 adjusted EBITDA. Fifty percent (50%) were issued on March 5, 2018. The remaining shares earned in connection with the February 2017 grant will vest and be issued as follows: 50% on 02/21/2019, and 50% on 02/21/2020, assuming continued employment on the relevant vesting date. Read SEC document |
| March 05, 2018 Filed Mar 26, 2018 20:31 UTC |
Matthews William RobertSenior VP, Operations, Quality
|
Tax withholdingCommon Stock | 886 | $19.15 | $16,966.90 |
DisclosureSEC source: 0000784199-18-000077 · certent-form4.xml · nonDerivative · entry 2 Matthews William Robert · CIK 0001649291 · Senior VP, Operations, Quality 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,883 F2 · shares: These shares were withheld upon the vesting of performance stock units to pay tax withholding obligations. Read SEC document |
| March 05, 2018 Filed Mar 26, 2018 20:31 UTC |
Matthews William RobertSenior VP, Operations, Quality
|
GrantCommon Stock | 5,652 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-18-000077 · certent-form4.xml · nonDerivative · entry 1 Matthews William Robert · CIK 0001649291 · Senior VP, Operations, Quality 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,769 F1 · shares: Represents performance stock units granted on February 21, 2017 and earned at approximately 90% of target based on 2017 adjusted EBITDA. Fifty percent (50%) were issued on March 5, 2018. The remaining shares earned in connection with the February 2017 grant will vest and be issued as follows: 50% on 02/21/2019, and 50% on 02/21/2020, assuming continued employment on the relevant vesting date. Read SEC document |
| February 19, 2018 Filed Feb 22, 2018 00:46 UTC |
Horton AmyVP, Chief Accounting Officer
|
Tax withholdingCommon Stock | 1,480 | $18.25 | $27,010.00 |
DisclosureSEC source: 0000784199-18-000032 · certent-form4.xml · nonDerivative · entry 1 Horton Amy · CIK 0001371523 · VP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,223 F1 · shares: Represent shares of restricted stock that were withheld for taxes on the grant vest date. Read SEC document |
| February 19, 2018 Filed Feb 22, 2018 00:50 UTC |
LEE DAVID ASHLEYExecutive VP, COO & CFO
|
Tax withholdingCommon Stock | 3,744 | $18.25 | $68,328.00 |
DisclosureSEC source: 0000784199-18-000034 · certent-form4.xml · nonDerivative · entry 1 LEE DAVID ASHLEY · CIK 0001112830 · Executive VP, COO & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 284,617 F1 · shares: Represent shares of restricted stock that were withheld for taxes on the grant vest date. Read SEC document |
| February 19, 2018 Filed Feb 22, 2018 00:44 UTC |
Capps Scott BVP, Clinical Research
|
Tax withholdingCommon Stock | 2,246 | $18.25 | $40,989.50 |
DisclosureSEC source: 0000784199-18-000030 · certent-form4.xml · nonDerivative · entry 1 Capps Scott B · CIK 0001409753 · VP, Clinical Research 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 131,827 F1 · shares: Represent shares of restricted stock that were withheld for taxes on the grant vest date. Read SEC document |
| February 19, 2018 Filed Feb 22, 2018 00:44 UTC |
Mackin James PPresident & CEO
|
Tax withholdingCommon Stock | 9,527 | $18.25 | $173,867.75 |
DisclosureSEC source: 0000784199-18-000028 · certent-form4.xml · nonDerivative · entry 1 Mackin James P · CIK 0001408470 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 299,282 F1 · shares: Represent shares of restricted stock that were withheld for taxes on the grant vest date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.